Clinical Trial Update: Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing customized neoadjuvant chemotherapy versus standard chemotherapy in patients with resectable stage IIIA (N2) non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN